Therapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn
International Journal of Molecular Sciences · 21.04.2026 · 27 (8) · 3688
DOI: 10.3390/ijms27083688 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.04.2026. Verfasst von Basanta Bhujel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul 05505, Republic of Korea. Hauptthemen laut MEDLINE: Sirolimus, Burns, Chemical, Eye Burns, Corneal Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences.
Abstract (Originalsprache)
Corneal alkali burn induces severe inflammation and tissue damage, leading to loss of corneal transparency and vision impairment. In this study, we evaluated the therapeutic potential of rapamycin (RAPA) compared with cyclosporine A (CsA) in a mouse model of corneal alkali burn, focusing on nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)–mediated inflammatory signaling and its impact on corneal wound healing and repair. Notably, RAPA robustly suppressed NF-κB activation, reduced infiltration of F4/80 macrophages and MPO neutrophils, and downregulated pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6. RAPA also markedly inhibited corneal neovascularization, as evidenced by decreased VEGF expression, reduced CD31 vessel formation, and suppression of Ang-2. RAPA substantially inhibited pathological fibrotic remodeling by reducing TGF-β1 expression, attenuating myofibroblast activation (α-SMA), decreasing collagen III deposition, and modulating matrix remodeling through suppression of MMP-9. Crucially, RAPA preserved epithelial barrier integrity by maintaining occludin expression, supported proper epithelial differentiation through sustained expression of CK12, and enhanced mucin layer stability by increasing MUC1 expression. It also restored tear production, reduced apoptotic cell death (TUNEL), and decreased dysregulated epithelial proliferation (Ki67). In conclusion, RAPA showed superior efficacy compared with CsA, primarily by enhancing corneal wound healing and facilitating structural and functional outcomes in the burned cornea. These findings underscore RAPA as a promising therapeutic candidate for ocular surface repair and vision restoration in extensive corneal injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul 05505, Republic of Korea.
- Department of Medical Science, Graduate School, University of Ulsan, Seoul 05505, Republic of Korea.
ORCID-Profile: Basanta Bhujel, Jae Yong Kim
Förderung
- National Research Foundation of Korea
- Asan Institute for Life Sciences
Zitieren
APA
Bhujel, B., Lee, H., Chung, H. S., & Kim, J. Y. (2026). Therapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn. International Journal of Molecular Sciences, 27(8), 3688. https://doi.org/10.3390/ijms27083688
Vancouver
Bhujel B, Lee H, Chung HS, Kim JY. Therapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn. International Journal of Molecular Sciences. 2026;27(8):3688. doi:10.3390/ijms27083688
BibTeX
@article{Bhujel2026,
author = {Bhujel, Basanta and Lee, Hun and Chung, Ho Seok and Kim, Jae Yong},
title = {Therapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {8},
pages = {3688},
doi = {10.3390/ijms27083688}
}
EUVIMED